Neutrosophic method to determine the rate of progress in the therapeutic treatments of Nephrotic Syndrome

Abstract

Nephrotic syndrome is characterized by five distinctive clinical elements: 1) Excess protein in urine (> 3.5 g/24 h); 2) Low levels of albumin in the blood (< 3.5 g/dL); 3) Presence of edema; 4) Elevated levels of cholesterol in the blood; 5) Presence of lipids in the urine. In general, a higher prevalence of this syndrome is observed in the pediatric population compared to adults. This research aims to develop a neutrosophic method to determine the index of therapeutic advances in Nephrotic Syndrome, obtaining a comprehensive view of treatment strategies, providing a solid basis for clinical decision making. Therapeutic advances for nephrotic syndrome were identified, focusing on maintaining proteinuria, eliminating edema and restoring albumin, treatment includes corticosteroids, diuretics and other options. Alternatives such as cyclophosphamide and adrenocorticotropic hormone are being explored, seeking to improve quality of life with an individualized approach.